Testing how a new psoriasis medication works in people with liver damage

This trial is testing how Hemay005 tablets work in people whose livers don't function normally. Researchers want to understand how the body processes this medication differently in people with mild or moderate liver damage compared to people with healthy livers. This information will help doctors figure out the right dose for patients with liver problems.

When your liver doesn't work well, it can change how your body processes medications. By studying this medication in people with different levels of liver damage, researchers can create safer, more effective treatment plans for psoriasis patients who also have liver problems.